Patents by Inventor Dieter Schmoll

Dieter Schmoll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AMPK Activators and Methods of Use Thereof
    Publication number: 20230338344
    Abstract: This disclosure to methods for treating or preventing particular symptoms and disorders which are associated with blood disorders using AMPK activators. Also disclosed are pharmaceutical composition comprising an AMPK activator for use in said methods.
    Type: Application
    Filed: March 28, 2023
    Publication date: October 26, 2023
    Applicant: Bioverativ Therapeutics Inc.
    Inventors: Pauline RIMMELÉ, Dieter SCHMOLL, Yannis HARA
  • Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
    Patent number: 8470841
    Abstract: Heterocyclic derivatives, processes for their preparation, medicaments comprising these compounds, and the use thereof. The invention relates to compounds of the formula I in which the radicals R1, R2, R3, R4, W, A, B, D, E, G, L, M, R, T and Y have the stated meanings, and to the physiologically tolerated salts thereof. The compounds are suitable for example for the treatment of the metabolic syndrome, insulin resistance, obesity and diabetes.
    Type: Grant
    Filed: July 7, 2009
    Date of Patent: June 25, 2013
    Assignee: Sanofi
    Inventors: Gerhard Zoller, Dieter Schmoll, Marco Mueller, Guido Haschke, Ingo Focken
  • Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical
    Patent number: 8207146
    Abstract: The present invention relates to substituted phenothiazines with a double bond and physiologically acceptable salts thereof, and their use as a medicament.
    Type: Grant
    Filed: March 16, 2010
    Date of Patent: June 26, 2012
    Assignee: Sanofi-Aventis
    Inventors: Stefanie Keil, Elisabeth Defossa, Dieter Schmoll, Axel Dietrich, Johanna Kuhlmann-Gottke, Karl-Christian Engel
  • HETEROCYCLIC COMPOUNDS, PROCESSES FOR THEIR PREPARATION, MEDICAMENTS COMPRISING THESE COMPOUNDS, AND THE USE THEREOF
    Publication number: 20110183998
    Abstract: Heterocyclic derivatives, processes for their preparation, medicaments comprising these compounds, and the use thereof. The invention relates to compounds of the formula I in which the radicals R1, R2, R3, R4, W, A, B, D, E, G, L, M, R, T and Y have the stated meanings, and to the physiologically tolerated salts thereof. The compounds are suitable for example for the treatment of the metabolic syndrome, insulin resistance, obesity and diabetes.
    Type: Application
    Filed: July 7, 2009
    Publication date: July 28, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Gerhard Zoller, Dieter Schmoll, Marco Mueller, Guido Haschke, Ingo Focken
  • PHENOTHIAZINE DERIVATIVE HAVING A DOUBLE BOND, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF AS A PHARMACEUTICAL
    Publication number: 20100261643
    Abstract: The present invention relates to substituted phenothiazines with a double bond and physiologically acceptable salts thereof, and their use as a medicament.
    Type: Application
    Filed: March 16, 2010
    Publication date: October 14, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Stefanie KEIL, Elisabeth DEFOSSA, Dieter SCHMOLL, Axel DIETRICH, Johanna KUHLMANN-GOTTKE, Karl-Christian ENGEL
  • Phenothiazin derivatives, method for the production thereof and use thereof as pharmaceuticals
    Patent number: 7732440
    Abstract: The invention relates to compounds of the formula I, wherein R1, R2, R3, R4, R5, R6, R7, A and B are as defined herein, the pharmaceutical compositions and the uses as pharmaceuticals.
    Type: Grant
    Filed: July 22, 2009
    Date of Patent: June 8, 2010
    Assignee: Sanofi-Aventis
    Inventors: Stefanie Keil, Elisabeth Defossa, Karl Schoenafinger, Dieter Schmoll, Axel Deitrich, Johanna Kuhlmann-Gottke, Karl-Christian Engel
  • PHENOTHIAZIN DERIVATES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS PHARMACEUTICALS
    Publication number: 20090325942
    Abstract: The invention relates to compounds of the formula 1, wherein R1, R2, R3, R4, R5, R6, R7, A and B are as defined herein, the pharmaceutical compositions and the uses as pharmaceuticals.
    Type: Application
    Filed: July 22, 2009
    Publication date: December 31, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: Stefanie KEIL, Elisabeth DEFOSSA, Karl SCHOENAFINGER, Dieter SCHMOLL, Axel DIETRICH, Johanna KUHLMANN-GOTTKE, Karl-Christian ENGEL
  • Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
    Patent number: 7498341
    Abstract: The invention relates to heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives and to the physiologically tolerated salts and physiologically functional derivatives thereof. The invention relates to compounds of the formula I in which the radicals have the stated meanings, and to the physiologically tolerated salts thereof. The compounds are suitable for example as medicaments for the prevention and treatment of type 2 diabetes.
    Type: Grant
    Filed: January 25, 2005
    Date of Patent: March 3, 2009
    Assignee: Sanofi Aventis Deutschland GmbH
    Inventors: Elisabeth Defossa, Dieter Kadereit, Sven Ruf, Thomas Klabunde, Dieter Schmoll, Andreas Herling, Karl-Ulrich Wendt
  • Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
    Patent number: 7470706
    Abstract: The invention relates to cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives and to the physiologically tolerated salts and physiologically functional derivatives thereof. The invention relates to compounds of the formula I in which the radicals have the stated meanings, and to the physiologically tolerated salts thereof. The compounds are suitable for example as medicaments for the prevention and treatment of type 2 diabetes.
    Type: Grant
    Filed: January 25, 2005
    Date of Patent: December 30, 2008
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Elisabeth Defossa, Dieter Kadereit, Thomas Klabunde, Dieter Schmoll, Andreas Herling, Karl-Ulrich Wendt, Sven Ruf
  • 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
    Patent number: 7402674
    Abstract: 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments The invention relates to 7-phenylamino-4-quinolone-3-carboxylic acid derivatives and to the physiologically tolerated salts and physiologically functional derivatives thereof. The invention relates to compounds of the formula I in which the radicals have the stated meanings, and to the physiologically tolerated salts thereof. The compounds are suitable for example as medicaments for the prevention and treatment of type 2 diabetes.
    Type: Grant
    Filed: January 25, 2005
    Date of Patent: July 22, 2008
    Assignee: Sanofi-Aventis Deutschland GmbH,
    Inventors: Elisabeth Defossa, Dieter Kadereit, Sven Ruf, Thomas Klabunde, Dieter Schmoll, Andreas Herling, Karl-Ulrich Wendt
  • 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
    Publication number: 20050182085
    Abstract: 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments The invention relates to 7-phenylamino-4-quinolone-3-carboxylic acid derivatives and to the physiologically tolerated salts and physiologically functional derivatives thereof. The invention relates to compounds of the formula I in which the radicals have the stated meanings, and to the physiologically tolerated salts thereof. The compounds are suitable for example as medicaments for the prevention and treatment of type 2 diabetes.
    Type: Application
    Filed: January 25, 2005
    Publication date: August 18, 2005
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Elisabeth Defossa, Dieter Kadereit, Sven Ruf, Thomas Klabunde, Dieter Schmoll, Andreas Herling, Karl-Ulrich Wendt
  • Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
    Publication number: 20050182086
    Abstract: The invention relates to heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives and to the physiologically tolerated salts and physiologically functional derivatives thereof. The invention relates to compounds of the formula I in which the radicals have the stated meanings, and to the physiologically tolerated salts thereof. The compounds are suitable for example as medicaments for the prevention and treatment of type 2 diabetes.
    Type: Application
    Filed: January 25, 2005
    Publication date: August 18, 2005
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Elisabeth Defossa, Dieter Kadereit, Sven Ruf, Thomas Klabunde, Dieter Schmoll, Andreas Herling, Karl-Ulrich Wendt
  • Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
    Publication number: 20050182087
    Abstract: Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments The invention relates to cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives and to the physiologically tolerated salts and physiologically functional derivatives thereof. The invention relates to compounds of the formula I in which the radicals have the stated meanings, and to the physiologically tolerated salts thereof. The compounds are suitable for example as medicaments for the prevention and treatment of type 2 diabetes.
    Type: Application
    Filed: January 25, 2005
    Publication date: August 18, 2005
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Elisabeth Defossa, Dieter Kadereit, Thomas Klabunde, Dieter Schmoll, Andreas Herling, Karl-Ulrich Wendt, Sven Ruf
  • Valve for controlling fluids
    Patent number: 6076800
    Abstract: A valve for controlling fluids, in which the valve member is adjusted by means of an actuating piston, which, together with a piezoelectric actuator piston, encloses a pressure chamber. In addition, the actuator piston and an affiliated piezoelectric stack are disposed in parallel radially next to the actuating piston, wherein upon excitation of the piezoelectric stack or adjustment of the actuator piston, the actuating piston executes a motion counter to the adjusting movement, and with its valve member, opens a relief bore.
    Type: Grant
    Filed: October 30, 1998
    Date of Patent: June 20, 2000
    Assignee: Robert Bosch GmbH
    Inventors: Rudolf Heinz, Dieter Kienzler, Roger Potschin, Klaus-Dieter Schmoll, Friedrich Boecking